Literature DB >> 6840420

Imprecision of new criteria for the oral glucose tolerance test.

V Massari, E Eschwège, A J Valleron.   

Abstract

Subjects selected from a centre specializing in diabetes detection have been classified using nine different methods of diagnosis including the recent criteria of the National Diabetes Data Group and the World Health Organization. The applicability of these two new criteria have been evaluated and compared with seven other previous criteria. The agreements and discrepancies between these criteria have been assessed. Application of the new criteria result in a major redistribution of subjects with abnormal glucose tolerance into a rare category of diabetes mellitus and a large category of 'impaired glucose tolerance'. An important percentage of our population (33%) is excluded from the three clinical classes circumscribed by the criteria of the National Diabetes Data Group. Among these subjects, two-thirds correspond to the subjects named 'non-diagnostic' by these authors and one-third are not classifiable. The need to allow for all possible oral glucose tolerance test responses is emphasized.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840420     DOI: 10.1007/bf00297390

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  26 in total

1.  CRITERIA FOR THE ORAL GLUCOSE TOLERANCE TEST IN PREGNANCY.

Authors:  J B O'SULLIVAN; C M MAHAN
Journal:  Diabetes       Date:  1964 May-Jun       Impact factor: 9.461

2.  The efficiency of screening tests for diabetes.

Authors:  Q R REMEIN; H L WILKERSON
Journal:  J Chronic Dis       Date:  1961-01

3.  Epidemiologic studies of diabetes in the Pima Indians.

Authors:  P H Bennett; N B Rushforth; M Miller; P M LeCompte
Journal:  Recent Prog Horm Res       Date:  1976

4.  Prospective study of 352 young patients with chemical diabetes.

Authors:  J B O'Sullivan; C M Mahan
Journal:  N Engl J Med       Date:  1968-05-09       Impact factor: 91.245

5.  Ten-year follow-up report on Birmingham Diabetes Survey of 1961. Report by the Birmingham Diabetes Survey Working Party.

Authors: 
Journal:  Br Med J       Date:  1976-07-03

6.  Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes").

Authors:  R J Jarrett; H Keen; J H Fuller; M McCartney
Journal:  Diabetologia       Date:  1979-01       Impact factor: 10.122

7.  Bimodality of fasting and two-hour glucose tolerance distributions in a Micronesian population.

Authors:  P Zimmet; S Whitehouse
Journal:  Diabetes       Date:  1978-08       Impact factor: 9.461

8.  Standardization of definition, classification, and reporting in diabetes-related epidemiologic studies.

Authors:  K M West
Journal:  Diabetes Care       Date:  1979 Mar-Apr       Impact factor: 19.112

9.  Oral glucose-tolerance tests and the diagnosis of diabetes: results of a prospective study based on the Whitehall survey.

Authors:  H A Sayegh; R J Jarrett
Journal:  Lancet       Date:  1979-09-01       Impact factor: 79.321

10.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

View more
  5 in total

1.  Effect of buspirone: An anxiolytic drug on blood glucose in humans.

Authors:  S K Ojha; M Nandave; C Sharma
Journal:  Indian J Clin Biochem       Date:  2006-09

2.  Diagnostic criteria.

Authors: 
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

3.  The oral glucose tolerance test: an objective method of interpretation.

Authors:  P Cohen; D Dix
Journal:  Acta Diabetol Lat       Date:  1984 Apr-Jun

4.  Prevalence of diabetes in a predominantly Asian community: preliminary findings of the Coventry diabetes study.

Authors:  D Simmons; D R Williams; M J Powell
Journal:  BMJ       Date:  1989-01-07

5.  The prediabetic period: review of clinical aspects.

Authors:  Sang Youl Rhee; Jeong-Taek Woo
Journal:  Diabetes Metab J       Date:  2011-04-30       Impact factor: 5.376

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.